Kaplan-Meier survival curves for patients with favorable cytogenetics and unfavorable cytogenetics (with 1q21 amplification, 17p or 13q deletion, 14q32 rearrangement) by FISH.

2A: The OS of patients with favorable cytogenetics(FISH-negative) was longer than those with unfavorable cytogenetics (with 1q21 amplification, 17p or 13q deletion, 14q32 rearrangement) by FISH, P=0. 045.

2B: The median PFS of patients with favorable cytogenetics(FISH-negative) was longer than those with unfavorable cytogenetics (with 1q21 amplification, 17p or deletion, 14q32 rearrangement) by FISH. 24. 0 months (95% CI: 18. 1–29. 9 months) vs 12. 0 months (95% CI: 8. 6–15. 4 months), P=0. 005.